CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling

Biochemical and Biophysical Research Communications(2023)

引用 1|浏览10
暂无评分
摘要
CMTM3 deficiency induces cardiac hypertrophy and aggravates hypertrophy and impaired cardiac function stimulated by angiotensin Ⅱ infusion. The expression of CMTM3 increases during cardiac hypertrophy, and the increased CMTM3 can inhibit further hypertrophy of cardiomyocytes by inhibiting MAPK signaling. Thus, CMTM3 plays a negative regulatory effect in the occurrence and development of cardiac hypertrophy.
更多
查看译文
关键词
cardiac hypertrophy,deficiency,mapk/erk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要